tirzepatide journal club In the SURMOUNT-1 trial (published in NEJM in July 2022), adults with #obesity treated with weekly tirzepatide, a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor SURPASS-CVOT Published: Large Trial Confirms

How long does it usually take to see results from the Semaglutide nutrition plan

Pseudotumor Cerebri (PTC) Hormonal IUDs like Mirena put users at an increased risk for pseudotumor cerebri (PTC), also known as a false brain tumor or idiopathic intracranial hypertension (IIH)

Last year, the Federal Trade Commission (FTC) challenged what it called "junk patent listings" by several pharmaceutical companies, including Novo Nordisk for its patent listing for Ozempic, Saxenda, and Victoza

Even Skin Tone: By controlling melanin synthesis, glutathione helps achieve a consistent and even skin tone across the face and body

But more recent research suggests that the drug slashes the risk of kidney failure and death in people who have type 2 diabetes and chronic kidney disease